Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks

The trillion-dollar market valuation club is currently dominated by the tech sector. Saudi Aramco is the sole exception. The other six members are all part of the Nasdaq’s Magnificent Seven. But if people keep getting prescriptions for popular weight loss drugs Mounjaro and Ozempic, it may not be long before the two Big Pharma firms that make those injectable medications wind up worth at least a trillion dollars as well.Eli Lilly (NYSE:LLY), the company behind Mounjaro and Zepbound, is now worth nearly $670 ...